Verastem | VSTM - الأصول





الأصول تغيير تاريخ
AbbVie USD 135.12B 1.35B 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
Curis USD 29.69M 9.72M 2026-03
Cytokinetics USD 1.92B 651.07M 2026-06
Gilead Sciences USD 51.41B 2.05B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Laboratory Of America USD 18.92B 392.3M 2026-09
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Verastem USD 227.81M 18.63M 2026-03